Retrospective case-control study on the outcomes of early minimally invasive pleural lavage for pleural empyema in oncology patients
- PMID: 34402204
- PMCID: PMC8520807
- DOI: 10.1111/1759-7714.14109
Retrospective case-control study on the outcomes of early minimally invasive pleural lavage for pleural empyema in oncology patients
Abstract
Background: Oncology patients carry a substantial risk of developing pleural empyema. Here, we report the preliminary results of our early video-assisted thoracoscopic surgery (VATS) lavage strategy in cases of empyema occurring in patients undergoing (radio-) chemotherapy.
Methods: This was a retrospective case-control study comparing early VATS lavage (test group, current therapy since January 2018, n = 46) versus VATS pleurectomy (historical control; before January 2018, n = 46).
Results: Five patients in the control group and one in the test group developed recurrence of empyema within 30 days. Complications were more severe and more frequently observed in the historical control group than in the test group (30/46 vs. 12/46 CI: 5%-95%, p = < 0.05). Early VATS lavage saved operating time, allowed a shorter ICU stay (2.6 days CI: 5%-95% vs. 5.1 days CI: 5%-95%, p = ns) and an earlier hospital discharge (6.1 days CI: 5%-95% vs. 13.5 days CI: 5%-95%, p < 0.05). Moreover, radio and/or chemotherapy could be reinitiated earlier (15 ± 20.5 days CI: 5%-95% vs. 40 ± 12 days CI: 5%-95%, p < 0.05).
Conclusions: In this retrospective cohort study, early VATS lavage was found to have a beneficial effect especially on hospital stay and enabling an earlier restart of radio- and/or chemotherapy.
Keywords: empyema; pleura; thoracic surgery.
© 2021 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
Conflict of interest statement
All authors have completed the ICMJE uniform disclosure form. The authors have no conflicts of interest to declare.
Figures




References
-
- Ferguson AD, Prescott RJ, Selkon JB, Watson D, Swinburn CR. The clinical course and management of thoracic empyema. QJM. 1996;89:285–9. - PubMed
-
- Davies CWH, Kearney SE, Gleeson FV, Davies RJ. Predictors of outcome and long‐term survival in patients with pleural infection. Am J Respir Crit Care Med. 1999;160:1682–7. - PubMed
-
- Ashbaugh DG. Empyema thoracis: factors influencing morbidity and mortality. Chest. 1991;99:1162–5. - PubMed
-
- Foster S, Maskell N. Bacteriology of complicated parapneumonic effusions. Curr Opin Pulm Med. 2007;13:319–23. - PubMed
-
- Heffner JE. Management of the patient with a malignant pleural effusion. Semin Respir Crit Care Med. 2010;31:723–33. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous